- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Pertuzumab (rhuMAb 2C4)
Total 5413 results
-
Elusys TherapeuticsCompleted
-
Tianjin Medical University Cancer Institute and...Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot yet recruitingHER2+ Early or Locally Advanced Breast Cancer
-
Sesen Bio, Inc.CompletedBladder CancerUnited States, Canada
-
Fudan UniversityRecruiting
-
German Cancer Research CenterUniversity Hospital Heidelberg; University Hospital DresdenNot yet recruitingRelapsed/Refractory Acute Myeloid Leukemia (AML)Germany
-
Brown UniversityPfizer; The Miriam Hospital; Rhode Island HospitalActive, not recruitingAcute Myeloid LeukemiaUnited States
-
New York Medical CollegeCompletedMyelodysplastic Syndrome | Acute Myelogenous LeukemiaUnited States
-
Hoffmann-La RocheActive, not recruiting
-
Novo Nordisk A/SCompletedObesitySpain, United States, France, Russian Federation, Canada, Colombia, South Africa, Norway, Denmark, Saudi Arabia, Sweden
-
Versailles HospitalCompletedAcute Myeloid LeukemiaFrance
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)RecruitingStage II Breast Cancer AJCC v6 and v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7 | Breast AdenocarcinomaUnited States
-
Gruppo Italiano Malattie EMatologiche dell'AdultoRecruitingAcute Myeloid LeukemiaItaly
-
Gilead SciencesTerminatedWaldenstrom MacroglobulinemiaUnited States
-
Gilead SciencesCompletedNon-Hodgkin's LymphomaUnited States
-
Roswell Park Cancer InstituteGlaxoSmithKlineActive, not recruitingClear Cell Renal Cell Carcinoma | Stage IV Renal Cell CancerUnited States
-
Boehringer IngelheimCompleted
-
Novartis PharmaceuticalsActive, not recruitingAdvanced HER2+Breast CancerBelgium, France, China, Italy, Spain, Malaysia, United States, Turkey
-
Dana-Farber Cancer InstituteGenentech, Inc.Active, not recruitingBreast Cancer | Stage II Breast Cancer | HER-2 Positive Breast Cancer | Stage III Breast CancerUnited States
-
Novo Nordisk A/SCompletedObesityKorea, Republic of, Thailand
-
AC Camargo Cancer CenterRecruitingBreast Neoplasms | HER2-positive Breast Cancer | Circulating Tumor CellBrazil
-
Dana-Farber Cancer InstituteGenentech, Inc.; Eisai Inc.TerminatedMetastatic Breast Cancer | HER2-positive Breast CancerUnited States
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI); Genzyme, a Sanofi CompanyTerminated
-
PfizerNo longer availableCD33 Positive Acute Myelogenous LeukemiaUnited States
-
Jules Bordet InstituteHoffmann-La Roche; Breast International Group; Institut Curie; International Drug...SuspendedHER2-positive Breast Cancer | ER-Negative Breast Cancer | PR-Negative Breast Cancer | Node-negative Breast CancerKorea, Republic of, France, Israel, Belgium, Switzerland, Australia
-
M.D. Anderson Cancer CenterCompletedMyelodysplastic Syndrome | Acute Myelogenous LeukemiaUnited States
-
The Methodist Hospital Research InstituteAstraZenecaRecruitingBreast CancerUnited States
-
TScan Therapeutics, Inc.RecruitingMelanoma | Cervical Cancer | Head and Neck Cancer | HPV-Related Malignancy | Ovarian Cancer | HPV-Related Carcinoma | HPV-Related Cervical Carcinoma | HPV Positive Oropharyngeal Squamous Cell Carcinoma | Non-small Cell Carcinoma | HPV - Anogenital Human Papilloma Virus Infection | HPV-Related Adenocarcinoma | HPV-Related Adenosquamous Carcinoma and other conditionsUnited States
-
Hoffmann-La RocheActive, not recruitingSolid TumorKorea, Republic of, China, France, Portugal, Spain, Brazil, Germany, Italy, Peru, Russian Federation, Japan, Ukraine, Costa Rica, Mexico, Poland
-
Hoffmann-La RocheCompletedEarly Breast CancerFrance, Spain, United States, Korea, Republic of, Canada, United Kingdom, Argentina, Belgium, Germany, Italy, Taiwan, Thailand, Japan, Brazil, Mexico, Czechia, Poland, Russian Federation, Ukraine
-
UCB PharmaWithdrawnSystemic Lupus ErythematosusUnited States, France, United Kingdom, Spain, Belgium, Netherlands, Canada, Brazil, Germany, Hungary, Czech Republic, Italy, Slovakia
-
UCB PharmaCompletedSystemic Lupus ErythematosusUnited States, Poland, Spain, Belgium, India, Ukraine, Brazil, United Kingdom, Hungary, Lithuania, Hong Kong
-
National Cancer Institute (NCI)CompletedClear Cell Renal Cell Carcinoma | Recurrent Renal Cell Carcinoma | Stage IV Renal Cell Cancer | Type 1 Papillary Renal Cell Carcinoma | Type 2 Papillary Renal Cell CarcinomaUnited States, Taiwan, Australia
-
Boehringer IngelheimCompletedArthritis, Rheumatoid
-
UCB PharmaCompletedSystemic Lupus ErythematosusJapan
-
National Cancer Institute (NCI)NRG OncologyCompletedMalignant Ovarian Epithelial Tumor | Ovarian Gynandroblastoma | Ovarian Sertoli-Leydig Cell Tumor | Ovarian Sex Cord Tumor With Annular Tubules | Ovarian Steroid Cell Tumor | Ovarian Granulosa Cell Tumor | Ovarian Sex Cord-Stromal Tumor | Ovarian Sex Cord-Stromal Tumor of Mixed or Unclassified Cell...United States
-
Boehringer IngelheimCompleted
-
Henan Cancer HospitalWithdrawnBreast Cancer | HER2-positive Breast CancerChina
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United States
-
Jonsson Comprehensive Cancer CenterNovartis; Seagen Inc.RecruitingAnatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC... and other conditionsUnited States
-
Midwest Center for Metabolic and Cardiovascular...HelainaCompletedImmune HealthUnited States
-
UCB PharmaCompletedSystemic Lupus ErythematosusUnited States, Brazil, Canada, France, Germany, Hungary, Italy, Mexico, Poland, Romania, Russian Federation, South Africa, Spain, Ukraine, United Kingdom, Australia, Belgium, Bulgaria, Czechia, Estonia, Israel, Korea, Republic of, T... and more
-
M.D. Anderson Cancer CenterKura Oncology, Inc.Not yet recruiting
-
M.D. Anderson Cancer CenterEisai Inc.CompletedMyelodysplastic Syndrome | Acute Myelogenous LeukemiaUnited States
-
UCB PharmaCompletedSystemic Lupus ErythematosusUnited States, Poland, Spain, Belgium, India, Ukraine, Brazil, United Kingdom, Hungary, Lithuania, Hong Kong
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedLeukemia, Myelocytic, Acute | Infusions, Intravenous
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedAcute Myeloid LeukemiaUnited States
-
Nektar TherapeuticsCompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...StemlineTherapeutics, Inc.RecruitingAcute Myeloid LeukemiaUnited States
-
University of California, San DiegoPfizer; Celgene CorporationCompletedAcute Myeloid LeukemiaUnited States
-
Nantes University HospitalWithdrawnCD22+ Relapsed/Refractory B-ALLFrance